The use of ferroptosis inducers to inhibit solute carrier family 7 member 11 (SLC7A11) or glutathione peroxidase 4 (GPX4) activity can enhance the sensitivity of tumor cells to radiotherapy (RT) [14,15]. The gene discussed is SLC7A11; the disease is neoplasm.